Published in:
04-09-2023 | Ultrasound | Interventional
Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules
Authors:
YiJie Dong, WeiWei Zhan, JianQiao Zhou, Ning Li, ZhenHua Liu, ShuJun Xia, XiaoFeng Ni, Juan Liu, JingWen Zhang, ShangYan Xu, ZhiFang Yang, Qing Hua
Published in:
European Radiology
|
Issue 3/2024
Login to get access
Abstract
Objective
This prospective observational study aimed to evaluate the efficacy of radiofrequency ablation (RFA) in treating ≤ 2 cm thyroid nodules with Bethesda IV cytology and C-TIRADS 4A categorization. Additionally, the factors influencing the completed absorption of ablation (CAA) were examined.
Methods
A total of 62 cases with 62 nodules underwent ultrasound-guided RFA and were included in the study. The volume reduction rate (VRR), CAA, and incomplete absorption of ablation (IAA) were assessed at the 1st, 3rd, 6th, and subsequent 6-month follow-ups. Clinical and ultrasound features were compared between the CAA and IAA groups at the 12th month follow-up.
Results
The average VRR at the 1st, 3rd, 6th, 12th month, and last follow-up were −88.6%, 16.0%, 59.7%, 82.0%, and 98.2%, respectively. More than half of the nodules achieved a 90% VRR after 1 year of RFA, with 88.7% demonstrating CAA at the end of the study (follow-up duration of 14 to 63 months). Nodules with grade 3 vascularity and those associated with chronic thyroiditis showed delayed CAA at the 12th month follow-up (p = 0.036 and 0.003, respectively).
Conclusion
RFA is an effective technique for treating ≤ 2 cm thyroid nodules with Bethesda IV cytology and C-TIRADS 4A categorization. Nodules with grade 3 blood supply and patients with chronic thyroiditis exhibited an impact on the completed absorption following RFA.
Clinical relevance statement
Our study has shown that radiofrequency ablation is an effective treatment for ≤ 2 cm thyroid nodules classified as Bethesda IV cytology. However, we identified that high vascularity of the nodule and chronic thyroiditis are adverse factors affecting the completed absorption of the ablation.
Key Points
•Radiofrequency ablation (RFA) is an effective technique for treatment of ≤ 2 cm Bethesda IV category thyroid nodules.
•Higher blood supply and chronic thyroiditis influence the completed absorption after RFA.